Jacobs Levy Equity Management, Inc Meira G Tx Holdings PLC Transaction History

Jacobs Levy Equity Management, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$5.04 - $8.6 $695,968 - $1.19 Million	-138,089 Reduced 64.08%	77,396 $400,000
Q4 2022 Feb 14, 2023	BUY	$5.8 - $8.98 $1.25 Million - $1.94 Million	215,485 New	215,485 $1.4 Million
Q2 2021 Aug 16, 2021	SELL	$12.85 - $16.2 $732,077 - $922,930	-56,971 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$13.84 - $17.8 $254,060 - $326,754	-18,357 Reduced 24.37%	56,971 $822,000
Q4 2020 Feb 16, 2021	BUY	$12.4 - $17.6 $433,181 - $614,838	34,934 Added 86.48%	75,328 $1.14 Million
Q3 2020 Nov 16, 2020	BUY	$11.59 - $14.93 $235,705 - $303,631	20,337 Added 101.4%	40,394 $535,000
Q2 2020 Aug 17, 2020	BUY	$11.79 - $15.97 $236,472 - $320,310	20,057 New	20,057 $251,000

39.7M

24.2K

30.7K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $192M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.